middle.news
Why Are Post-Prostatectomy Patients Choosing LTR Pharma’s SPONTAN Nasal Spray?
10:34pm on Friday 29th of August, 2025 AEST
•
Healthcare
Read Story
Why Are Post-Prostatectomy Patients Choosing LTR Pharma’s SPONTAN Nasal Spray?
10:34pm on Friday 29th of August, 2025 AEST
Key Points
100% patient satisfaction with SPONTAN nasal spray in post-prostatectomy ED
All patients preferred SPONTAN over traditional oral ED treatments
Large global market with ~8,500 prostatectomies annually in Australia alone
Clinical validation presented at Asia-Pacific Prostate Cancer Conference
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Ltr Pharma (ASX:LTP)
OPEN ARTICLE